The investigation analyzed 142 samples representing 52 rice products. Notably, 17 products contained average inorganic arsenic concentrations of at least 100 parts per billion. Rice type significantly influenced average concentrations.
Overall, 72 percent of targeted surveillance samples were deemed satisfactory. FSA flagged imported, niche products, like Dubai-style chocolates, South Asian snacks, and ashwagandha supplements, as especially problematic.
The resources were produced through the Cell-Cultivated Products Sandbox Program and cover hygiene requirements; identity, production, and microbiology; product applications; and novel food taste trials.
The 102nd meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) took place in June 2026 in Nanjing, China. Key outcomes included the establishment of new, temporary acceptable daily intakes (ADIs) for two substances.
The vaccine provided 89 percent protection against S. sonnei infection compared with the placebo. Vaccinated participants also experienced less severe symptoms and lower levels of bacterial shedding. The vaccine is being developed as drug resistance among Shigella continues to increase.
The plan establishes the Codex Alimentarius Commission’s priorities for the next six years to strengthen the development of international food safety and quality standards while considering evolving and emerging global challenges.
The Keep Food Containers Safe from PFAS Act (H.R. 9593) would amend the Federal Food, Drug, and Cosmetic Act to prohibit food packaging containing intentionally added per- and polyfluoroalkyl (PFAS) substances, a.k.a. “forever chemicals.”
The study represents the first publication of a large FDA dataset on ochratoxin A (OTA) occurrence in U.S. foods. OTA was detected above the limit of detection in 3.5 percent of all samples (which were targeted based on their susceptibility to contamination).
L. monocytogenes is the fourth-leading foodborne illness-related cause of death in the U.S. Despite continued efforts, listeriosis incidence rates have not declined, prompting FDA to launch a series of public engagements to discuss best practices for managing the pathogen.